Aug 3, 2026 | Biosimilars, Cost Savings, Drug costs, Pharmacy, Prescription, Rx Costs, Savings, Specialty Drugs
Specialty drug costs are projected to jump another 32% by 2028, according to the Pharmacy Strategies Group. While greater utilization remains the primary driver, lower-cost biosimilars can help pharmacy plans offset the increase. Biosimilars’ overall market share...
May 4, 2026 | Biosimilars, Cost Savings, Drug costs, MedBen Rx, Rebates, Rx Costs, Savings
Specialty drugs account for more than half of total drug spend and are often the largest cost driver for employer pharmacy plans. A recent BenefitPRO article points to biosimilars as a practical solution — and for MedBen Rx clients, the effect is already clear, with...
May 1, 2026 | Cost Savings, Forensic claims review, Fraud Control Unit, Medicaid, Recovery Audit Contractor (RAC), Savings
In the federal government’s latest push against Medicaid fraud and waste, the Trump administration will require all 50 states to submit plans outlining how they will revalidate high-risk providers. This heightened focus on accountability mirrors MedBen’s ongoing...
Jan 27, 2026 | Announcements, Claims, Claims Management, Cost Savings, Discounts, Forensic claims review, MedBen News, Preferred provider organization (PPO), Savings
$22.38 per employee per monthThat’s the average savings MedBen clients realized in 2025 through forensic claims review — the largest annual per-employee impact since the service launched in 2007. Savings like these don’t happen by accident — or by auto-adjudication....
Dec 1, 2025 | Case Studies, Cost Savings, MedBen Rx, Patient assistance, Patient coupons, Pharmacy, Pharmacy Benefits Manager (PBM), Rx Costs, Savings
A new MedBen Rx client realized $1.19 million in combined plan and member savings in their first year – a 45.7% reduction, surpassing the $1.05 million projected savings. Per-member-per-month (PMPM) pharmacy costs tell the story: $233 under the previous PBM vs. just...
Oct 21, 2025 | biologics, Biosimilars, Cost Savings, Humira, Rx Costs, Savings, Stelara
To help clients more efficiently access the cost savings of biosimilars, MedBen Rx is introducing an advance notice model. Rather than requiring approval each time a new biosimilar becomes available, this proactive approach automatically adds new biosimilars to your...
